Nippon Shinyaku Co., Ltd. (NPPNY)
OTCMKTS · Delayed Price · Currency is USD
9.00
-0.20 (-2.17%)
Jan 13, 2026, 4:00 PM EST
Nippon Shinyaku Market Cap
Nippon Shinyaku has a market cap or net worth of $2.41 billion as of January 13, 2026. Its market cap has increased by 30.27% in one year.
Market Cap
2.41B
Enterprise Value
2.01B
Revenue
1.08B
Ranking
n/a
PE Ratio
11.15
Stock Price
$9.00
Market Cap Chart
Since August 18, 1993, Nippon Shinyaku's market cap has increased from 950.72M to 2.41B, an increase of 153.16%. That is a compound annual growth rate of 2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 2.42B | -0.56% |
| Dec 30, 2025 | 2.44B | 42.49% |
| Dec 30, 2024 | 1.71B | -28.36% |
| Dec 29, 2023 | 2.39B | -37.52% |
| Dec 30, 2022 | 3.82B | -18.47% |
| Dec 30, 2021 | 4.69B | 6.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Glass House Brands | 711.87M |
| Elite Pharmaceuticals | 521.08M |
| Northwest Biotherapeutics | 409.64M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 386.18M |
| CytoDyn | 343.01M |
| Silence Therapeutics | 260.73M |